non-invas evalu long-term cardiac effect captopril system sclerosi impair left ventricular LV function patient system sclerosi sscl intermitt vasospast process myocardium develop myocardi dysfunct vasodil use treatment cardiac dysfunct patient sscl studi long-term effect captopril myocardi function patient sscl twenty-two patient sscl patient diffus scleroderma patient crest syndrom i.e calcinosi raynaud phenomenon oesophag hypomotil sclerodactyli telangiectasia mean doppler echophonocardiographi treatment captopril bodi month signific differ heart rate systol diastol blood pressur end-systol blood pressur total peripher resist LV diamet treatment captopril treatment signific effect LV function pre-eject period pep ratio pre-eject period LV eject time mitral e-point septal separ adjust LV end-diastol diamet eject fraction isovolum relax time left atrial index doppler peak earli ventricular fill veloc isovolum index systol diastol LV function indic patient sscl captopril treatment mean period year effect captopril due vasodil myocardi vessel direct effect renin-angiotensin system heart 